<DOC>
	<DOC>NCT01083017</DOC>
	<brief_summary>The purpose of this study is to investigate the epidemiology of resistant hypertension, evaluate the efficacy and feasibility of a standardized drug treatment regimen (including the randomization of two doses of the diuretic used - chlorthalidone), study two interventions in the group of patients that is non-compliant, and study environmental and genetic variables of individuals with resistant hypertension in a family design.</brief_summary>
	<brief_title>Resistant Arterial Hypertension Cohort Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>informed consent resistant hypertension at the moment of inclusion 18 years or more, both sexes are included women at reproductive age: consenting to use oral contraception patients mentally impaired or unable to give informed consent patients speaking only a foreign language other than French, German, or English patients living far away, making the study visits not practical</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>